Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
13.90
-0.70 (-4.79%)
Apr 29, 2026, 10:52 AM EDT - Market open

Tenax Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-52.6-17.6-7.71-11.05-32.47
Upgrade
Depreciation & Amortization
--0.010.110.11
Upgrade
Loss (Gain) From Sale of Assets
--0-0-
Upgrade
Loss (Gain) From Sale of Investments
----0.01
Upgrade
Stock-Based Compensation
19.161.130.190.370.77
Upgrade
Other Operating Activities
-0.020.02021.34
Upgrade
Change in Accounts Receivable
---0.31-0.36-0.02
Upgrade
Change in Accounts Payable
2.881.061.65-0.34-0.54
Upgrade
Change in Other Net Operating Assets
-5.250.580.24-0.12-0.04
Upgrade
Operating Cash Flow
-35.8-14.81-5.9-11.39-10.86
Upgrade
Capital Expenditures
----0-0.01
Upgrade
Sale of Property, Plant & Equipment
--0--
Upgrade
Investment in Securities
----0.46
Upgrade
Investing Cash Flow
--0-00.45
Upgrade
Short-Term Debt Repaid
--0.5-0.62--
Upgrade
Total Debt Repaid
--0.5-0.62--
Upgrade
Net Debt Issued (Repaid)
--0.5-0.62--
Upgrade
Issuance of Common Stock
15.30.07000.54
Upgrade
Other Financing Activities
23.22100.314.197.939.19
Upgrade
Financing Cash Flow
38.5199.8713.577.939.74
Upgrade
Net Cash Flow
2.7185.067.67-3.46-0.67
Upgrade
Free Cash Flow
-35.8-14.81-5.9-11.39-10.86
Upgrade
Free Cash Flow Per Share
-0.91-0.97-23.76-619.37-844.53
Upgrade
Cash Interest Paid
-0.02---
Upgrade
Levered Free Cash Flow
-18.44-9.41-3.79-7.77-19.33
Upgrade
Unlevered Free Cash Flow
-18.44-9.39-3.77-7.76-19.33
Upgrade
Change in Working Capital
-2.361.641.58-0.82-0.61
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.